Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi

Michele Merli; Stefano Luminari; Lucia Farina; Federica Cocito; Irene Defrancesco; Guido Gini; Annalisa Arcari; Greta Scapinello; Massimo Gentile; Maria Goldaniga; Giacomo Loseto; Emanuele Cencini; Antonino Greco; Anna Lia Molinari; Andrea Ferrario; Benedetta Bianchi; Barbara Mora; Lorenza Bertù; Vincenzo Saturni; Fabio Bergamini; Nicole Fabbri; Francesca Gaia Rossi; Silvia Bolis; Francesco Passamonti; Luca Arcaini

doi:10.1038/s41409-020-0967-5

Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi

Bone Marrow Transplant. 2020 Dec;55(12):2350-2353. doi: 10.1038/s41409-020-0967-5. Epub 2020 Jun 15.

Authors

Michele Merli¹, Stefano Luminari^{2

3}, Lucia Farina⁴, Federica Cocito⁵, Irene Defrancesco⁶, Guido Gini⁷, Annalisa Arcari⁸, Greta Scapinello⁹, Massimo Gentile¹⁰, Maria Goldaniga¹¹, Giacomo Loseto¹², Emanuele Cencini¹³, Antonino Greco¹⁴, Anna Lia Molinari¹⁵, Andrea Ferrario¹⁶, Benedetta Bianchi¹⁶, Barbara Mora¹⁶, Lorenza Bertù¹⁶, Vincenzo Saturni¹⁷, Fabio Bergamini¹⁸, Nicole Fabbri¹⁸, Francesca Gaia Rossi¹¹, Silvia Bolis⁵, Francesco Passamonti¹⁶, Luca Arcaini^{6

18}

Affiliations

¹ Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy. michele.merli@asst-settelaghi.it.
² Hematology Unit, Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy.
³ Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
⁴ Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁵ Department of Hematology, S. Gerardo University Hospital, Monza, Italy.
⁶ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
⁷ Department of Hematology, Ospedali Riuniti, Ancona, Italy.
⁸ Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy.
⁹ Hematology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
¹⁰ Onco-hematology, Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
¹¹ Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
¹² Hematology, IRCCS Ospedale Oncologico Giovanni Paolo II, Bari, Italy.
¹³ Hematology, Azienda Ospedaliera Senese, University of Siena, Siena, Italy.
¹⁴ Division of Hematology, Ospedale G. Panico, Tricase, Lecce, Italy.
¹⁵ Hematology, Ospedale degli Infermi, Rimini, Italy.
¹⁶ Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy.
¹⁷ Apheresis Unit of Immunohematology and Transfusional Service, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, Varese, Italy.
¹⁸ Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

PMID: 32541690
DOI: 10.1038/s41409-020-0967-5

No abstract available

Publication types

Letter
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Bendamustine Hydrochloride
Hematopoietic Stem Cell Mobilization
Humans
Lymphoma, Non-Hodgkin*
Nitrogen Mustard Compounds*
Rituximab

Substances

Nitrogen Mustard Compounds
Rituximab
Bendamustine Hydrochloride